Takeda Pharmaceutical
TAK
#398
Rank
$58.50 B
Marketcap
$18.52
Share price
1.37%
Change (1 day)
24.55%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): $3.32 Billion USD

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are $29.86 Billion USD. , an increase over its 2024 earnings that were of $2.23 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 $3.32 B49.03%
2024 $2.23 B-2.41%
2023 $2.28 B-28.14%
2022 $3.18 B-40.9%
2021 $5.38 B78.24%
2020 $3.02 B246.1%
2019 $0.87 B-48.79%
2018 $1.70 B-23.64%
2017 $2.23 B21.7%
2016 $1.83 B-253.01%
2015 -$1.2 Billion-159.65%
2014 $2.00 B13%
2013 $1.77 B2.46%
2012 $1.73 B-57.05%
2011 $4.03 B-10.49%
2010 $4.51 B-3.99%
2009 $4.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$33.55 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$16.35 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$10.19 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$8.97 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$7.69 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$22.42 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$9.89 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-$0.8 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$0.87 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India